26 March 2025
Dr. Papadatos-Pastos was invited to speak at the Royal Society of Medicine on the vital role of next-generation sequencing (NGS) in the treatment of non-small cell lung cancer (NSCLC). His talk focused on how to effectively integrate advances in molecular profiling into routine clinical practice, while also addressing current challenges and limitations in implementation.
He emphasised the transformative impact of our growing understanding of cancer biology—particularly when combined with novel therapies—on the treatment landscape of lung cancer. These advancements have not only helped patients live longer but, in some cases, have contributed to achieving durable responses and potential cures.
Dr. Papadatos-Pastos at the Royal Society of Medicine